Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer

Molecular Cancer Therapeutics

Volumn 2, Issue 1, 2003, Pages 1-7

  Chu, Jingsong ^a   Lloyd, Frank L ^a   Trifan, Ovidiu C ^b   Knapp, Brian ^a   Rizzo, Maria Teresa ^a  

^a METHODIST RESEARCH INSTITUTE   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENDOTHELIAL CELL GROWTH FACTOR; ISOENZYME; LYMPHOKINE; MEMBRANE PROTEIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N-(2-CYCLOHEXYLOXY-4-NITROPHENYL)METHANESULFONAMIDE; NITROBENZENE DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; PTGS1 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; SIGNAL PEPTIDE; SULFONAMIDE; VASCULOTROPIN; VASCULOTROPIN A;

ARTICLE; CAPILLARY; CELL CULTURE; CELL DIVISION; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PANCREAS TUMOR; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION;

CAPILLARIES; CELL DIVISION; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HOMEOSTASIS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LYMPHOKINES; MEMBRANE PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NITROBENZENES; PANCREATIC NEOPLASMS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SULFONAMIDES; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0038489501     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Warshaw, A. L., and Fernandez-Del Castillo, C. Pancreatic carcinoma. N. Engl. J. Med., 326: 455-465, 1992.
2. Rosenberg, L. Treatment of pancreatic cancer. Int. J. Pancreatol., 22: 81-93, 1997.
3. Greenlee, R., Hill-Harmon, M., Taylor, M., and Thurm, M. Cancer statistics 2001. Cancer J. Clin., 51: 5-36, 2001.
4. Friess, H., Kleeff, J., Korc, M., and Buchler, M. W. Molecular aspects of pancreatic cancer and future perspectives. Dig. Surg., 16: 281-290, 1999. (Pubitemid 29376329)
5. Needleman, P., Turk, J., Jakschik, B. A., Morrison, A. R., and Lefkowith, J. B. Arachidonic acid metabolism. Annu. Rev. Biochem., 55: 69-102, 1986. (Pubitemid 16070764)
6. Williams, C. D., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 270: G393-G400, 1996. (Pubitemid 26103875)
7. Herschman, H. R. Prostaglandin synthase 2. Biochim. Biophys. Acta, 1299: 125-140, 1996. (Pubitemid 26007741)
8. Williams, C. R., Mann, M., and DuBois, R. N. The role of cyclooxygenases in inflammation, cancer and development. Oncogene, 18: 7908-7916, 1999. (Pubitemid 30066236)
9. Subbaramaiah, K., Telang, N., Ramonetti, J. T., Araki, R., DeVito, B., Weksler, B. B., and Dannenberg, A. J. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res., 54: 4424-4429, 1996. (Pubitemid 26330450)
10. Wilson, K. T., Fu, S., Ramanujam, K. S., and Meltzer, S. J. Increased expression of inducible nitric oxide and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinoma. Cancer Res., 58: 2929-2934, 1998. (Pubitemid 28335064)
11. Hida, T., Yatabe, Y., Achiwa, H., Muramatzu, H., Kozaki, K., Nakamura, S., Ogawa, M., Mitsudomi, T., Sugiura, T., and Takahashi, T. Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinoma. Cancer Res., 58: 3761-3764, 1998. (Pubitemid 28405625)
12. Sheehan, K. M., Sheehan, K., O'Donoghue, D. P., MacSweeeny, F., Conroy, R. M., Fizdgerald, D. J., and Murray, F. E. The relationship between cyclooxygenase 2 expression and colorectal cancer. JAMA, 282: 1254-1257, 1999. (Pubitemid 29468497)
13. Oshima, M., Dinchuk, J. E., Kragman, S. L., Oshima, H., Hanock, B. Kwong, E., Trzaskos, J. M., Evans, J. F., and Taketo, M. M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase-2 (COX-2). Cell, 87: 803-809, 1996.
14. Liu, C. H. Chang, S-H., Narko, K., Trifan, O. C., Wu, M-T., Smith, E., Haudenschild, C., Lane, T. F., and Hla, T. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J. Biol. Chem., 276: 18563-18569, 2001.
15. Kawamori, T., Rao, C. V., Seibert, K., and Reddy, B. S. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor against colon carcinogenesis. Cancer Res., 58: 409-412, 1998. (Pubitemid 28087398)
16. Reddy, B. S., Rao, C. V., and Seibert, K. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res., 56: 4566-4569, 1996. (Pubitemid 26338047)
17. Dannenberg, A. J., Altorki, N. K., Boyle, J. O., Dang, C., Howe, L. R., Weksler, B. B., and Subbaramaiah, K. Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer. Lancet Oncol., 2: 544-551, 2001. (Pubitemid 33586867)
18. Masferrer, J. L., Leahy, K. M., Koki, A. T., Zweifel, B. S., Settle, S. L., Woerner, B. M., Edwards, D. A., Flickinger, A. G., Moore, R. J., and Seibert, K. Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res., 60: 1306-1311, 2000. (Pubitemid 30151999)
19. Willliams, C. S., Tsuji, M., Reese, J., Dey, S. K., and DuBois, R. N. Host cyclooxygenase-2 modulates carcinoma growth. J. Clin. Investig., 105: 1589-1594, 2000. (Pubitemid 30390309)
20. Koshiba, T., Hosotani, R., Miyamoto, Y., Wada, M., Lee, J-U. Fujimoto, K., Tsuji, S., Nakajima, S., Doi, R., and Imamura, M. Immunohistochemical analysis of cyclooxygenase-2 expression in pancreatic tumors. Int. J. Pancreatol., 26: 69-76, 1999.
21. Okami, J., Yamamoto, H., Fujiwara, Y., Tsujie, M., Kondo, M., Noura, S., Oshima, S., Nagano, H., Dono, K., Umeshita, K., Ishikawa, O., Sakon, M., Matsuura, N., Nakamori, S., and Monden, M. Overexpression of cyclooxygenase-2 in carcinoma of the pancreas. Clin. Cancer Res., 5: 2018-2024, 1999. (Pubitemid 29399253)
22. Kokawa, A., Kondo, H., Gotoda, T., Ono, H., Saito, D., Nakadaira, S., Kosuge, T., and Yoshida, S. Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors. Cancer (Phila.), 91: 333-338, 2001. (Pubitemid 32099234)
23. Tucker, O. N., Dannenberg, A. J., Yang, E. K., Zhan, F., Teng, L., Daly, J. M., Soslow, R. A., Masferrer, J. L., Woerner, B. M., Koki, A. T., and Fahey, T. J., III. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res., 59: 987-990, 1999. (Pubitemid 29135954)
24. Chen, W. H., Horoszewicz, J. S., Leong, S. S., Shimano, T., Penetrante, R., Sanders, W. H., Berjian, R., Douglass, H. O., Martin, E. W., and Chu, T. M. Human pancreatic adenocarcinoma: in vitro and in vivo morphology of a new tumor line established from ascites. In Vitro, 18: 24-34, 1982. (Pubitemid 12116070)
25. Tan, M. H., Nowak, N. J., Loor, R., Ochi, H., Sandberg, A. A., Lopez, C., Pickren, J. M., Berjian, R., Douglass, O. H., and Chu, T. M. Characterization of a new primary human pancreatic tumor line. Cancer Investig., 4: 15-23, 1986. (Pubitemid 16103427)
26. Rizzo, M. T., and Yu. W-Y. Arachidonic acid induces endothelin-1 gene expression in vascular endothelial cells. J Cell. Biochem., 75: 724-733, 1999.
27. Rizzo, M. T., Nguyen, E., M. Aldo-Benson, M., and Lambeau, G. Secreted phospholipase A2 induces migration of vascular endothelial cells. Blood, 96: 3809-3815, 2000.
28. Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., and DuBois, R. N. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell, 93: 705-716, 1998. (Pubitemid 28257578)
29. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblasts growth factor. Lab. Investig., 67: 519-528, 1992.
30. Smith, R. A. Evaluation of cross-species reactivity of antibodies to human antigens in animal models using immunoperoxidase techniques. J. Histotechnol., 13: 255-269, 1990.
31. Bradford, M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
32. Rizzo, M. T., Regazzi, E., Garau, D., Akard, L., Dugan, M., Boswell, H. S., Rizzoli, V., and Carlo-Stella, C. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells. Cancer Res., 59: 5047-5053, 1999. (Pubitemid 29472914)
33. Yip-Schneider, M. T., Barnard, D. S., Billings, S. D. Chenge, L., Heilman, D. K., Lin, A., Marshall, S. J., Crowell, P. L., Marshall, M. S., and Sweeney, C. J. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis (Lond.), 21: 139-146, 2000.
34. Rizzo, M. T., Pudlo, N., Farrell, L., and Leaver, A. Specificity of arachidonic acid-induced inhibition of growth and activation of c-jun kinases and p-38 mitogen-activated protein kinase in hematopoietic cells. Prostaglandins Leukot. Essent. Fatty Acids, 66: 31-40, 2002. (Pubitemid 34717686)
35. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. (Bethesda), 82: 4-6, 1990. (Pubitemid 20020880)
36. Futaki, N., Takahashi, S., Yokoyama, I., Higuchi, S., and Otomo, S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47: 55-59, 1994. (Pubitemid 24053843)
37. Fujimoto, K., Hosotani, R., Wada, M., Lee, J. U., Koshiba, T., Miyamoto, Y., Tsuji, S., Nakajima, S., Doi, R., and Imamura, R. Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer and its relationship to angiogenesis. Eur. J. Cancer, 34: 1439-1447, 1998. (Pubitemid 28370938)
38. Down, N. P., Scully, M., Adderley, S. R., Cunningham, A. J., and Fitzgerald, D. J. Inhibition of cyclooxygenase-2 aggravates doxorubicin-mediated cardiac injury in vivo. J. Clin. Investig., 108: 585-590, 2001. (Pubitemid 32777738)
39. Ikeda, N., Adachi, M., Taki, T., Huang, C., Hashida, H., Takabayashi, A., Sho, M., Nakajima, Y., Kanehiro, H., Hisanaga, M., Nakano, H., and Miyake, M. Prognostic significance of angiogenesis in human pancreatic cancer. Br. J. Cancer, 79: 1553-1563, 1999. (Pubitemid 29116820)
40. Kuehn, R., Lelkes, P. I., Bloechle, C., Niendorf, A., and Izbicki, J. R. Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatitis diseases: angiogenesis in chronic pancreatitis and in pancreatic cancer. Pancreas, 18: 96-103, 1999. (Pubitemid 29011342)
41. Hotz, H., Reber, H. A., Hotz, B., Sanghavi, P. C., Yu, T., Foitzik, T., Buhr, H. J., and Hines, O. J. Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth. J. Gastrointest. Surg., 5: 131-138, 2001. (Pubitemid 33652050)
42. Yanagi, K., Onda, M., and Uchida, E. Effect of angiostatin on liver metastasis of pancreatic cancer in hamsters. Jpn. J. Cancer Res., 91: 723-730, 2000. (Pubitemid 30612357)
43. Molina, M. A., Sitija-Arnau, M., Lemoine, M. G., Frazier, M. L., and Sinicrope, F. A. Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs. Cancer Res., 59: 4356-4362, 1999. (Pubitemid 29418754)
44. Yuan, C. D., Mandal, A. K., Zhang, Z., and Mukherjee, A. B. Transcriptional regulation of cyclooxygenase-2 gene expression: novel effects of anti-inflammatory drugs. Cancer Res., 60: 1084-1091, 2000. (Pubitemid 30129549)
45. Ding, X. Z., Tong, W. G., and Adrian, T. E. Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells. Anticancer Res., 20: 2625-2631, 2000. (Pubitemid 30614476)
46. Trifan, O. C., Smith, R. M., Thompson, B. D., and Hla, T. Overexpression of cyclooxygenase-2 induces cell cycle arrest. Evidence for a prostaglandin-independent mechanism. J. Biol. Chem., 274: 34141-34147, 1999. (Pubitemid 129511751)